Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Ignasi Tusquets"'
Autor:
Paula Peremiquel-Trillas, Yolanda Benavente, Mayte Martín-Bustamante, Delphine Casabonne, Beatriz Pérez-Gómez, Inés Gómez-Acebo, Anna Oliete-Canela, Marta Diéguez-Rodríguez, Ignasi Tusquets, Pilar Amiano, Lourdes Mengual, Eva Ardanaz, Rocío Capelo, Antonio J. Molina de la Torre, Dolores Salas Trejo, Guillermo Fernández-Tardón, Virginia Lope, José J. Jimenez-Moleon, Rafael Marcos-Gragera, Trinidad Dierssen-Sotos, Mikel Azpiri, Montse Muñoz, Marcela Guevara, Tania Fernández-Villa, Ana Molina-Barceló, Nuria Aragonés, Marina Pollán, Gemma Castaño-Vinyals, Juan Alguacil, Manolis Kogevinas, Silvia de Sanjosé, Laura Costas
Publikováno v:
Environment International, Vol 122, Iss , Pp 389-399 (2019)
Background: Alkylphenolic compounds are chemicals with endocrine disrupting properties that have been widely used in industry with important changes in their usage over time. Few epidemiologic studies have evaluated the effect of alkylphenolic compou
Externí odkaz:
https://doaj.org/article/8fa1a8787ee241ebaa07dd2cc2ea6ca3
Autor:
Marta Pineda-Moncusí, Natalia Garcia-Giralt, Adolfo Diez-Perez, Ignasi Tusquets, Sonia Servitja, Joan Albanell, Daniel Prieto-Alhambra, Xavier Nogués
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Tamoxifen (TAM) and aromatase inhibitor (AI) therapies have been associated with increased risk of thromboembolic and cardiovascular events, respectively, in addition to other side effects. This study analysed the risk of these events and
Externí odkaz:
https://doaj.org/article/4186b17c422e4dacbef014c407298f28
Autor:
David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, Michael P. Schroeder, Ana Vivancos, Ana Rovira, Ignasi Tusquets, Joan Albanell, Jordi Rodon, Josep Tabernero, Carmen de Torres, Rodrigo Dienstmann, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Publikováno v:
Genome Medicine, Vol 10, Iss 1, Pp 1-8 (2018)
Abstract While tumor genome sequencing has become widely available in clinical and research settings, the interpretation of tumor somatic variants remains an important bottleneck. Here we present the Cancer Genome Interpreter, a versatile platform th
Externí odkaz:
https://doaj.org/article/0e69b340b3c34623b79163ba6ddce679
Autor:
Aura Muntasell, Mariona Cabo, Sonia Servitja, Ignasi Tusquets, María Martínez-García, Ana Rovira, Federico Rojo, Joan Albanell, Miguel López-Botet
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
Overexpression of the human epidermal growth factor receptor 2 (HER2) defines a subgroup of breast tumors with aggressive behavior. The addition of HER2-targeted antibodies (i.e., trastuzumab, pertuzumab) to chemotherapy significantly improves relaps
Externí odkaz:
https://doaj.org/article/05232de585a545e1b4b0e14b87019fea
Autor:
Inés Gómez-Acebo, Trinidad Dierssen-Sotos, Camilo Palazuelos, Beatriz Pérez-Gómez, Virginia Lope, Ignasi Tusquets, M Henar Alonso, Victor Moreno, Pilar Amiano, Antonio José Molina de la Torre, Aurelio Barricarte, Adonina Tardon, Antonio Camacho, Rosana Peiro-Perez, Rafael Marcos-Gragera, Montse Muñoz, Maria Jesus Michelena-Echeveste, Luis Ortega Valin, Marcela Guevara, Gemma Castaño-Vinyals, Nuria Aragonés, Manolis Kogevinas, Marina Pollán, Javier Llorca
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0159672 (2016)
The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased r
Externí odkaz:
https://doaj.org/article/4d6bee4352114fcba6f72ea89c0a406e
Autor:
Sonia Servitja, Tamara Martos, Maria Rodriguez Sanz, Natalia Garcia-Giralt, Daniel Prieto-Alhambra, Laia Garrigos, Xavier Nogues, Ignasi Tusquets
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 7 (2015)
Aromatase inhibitors (AIs) are routinely used in the adjuvant treatment of women with hormone receptor-positive early breast cancer. Patients who receive AIs have an increased risk of bone loss and arthralgia compared with those treated with tamoxife
Externí odkaz:
https://doaj.org/article/642cfe6396994171aff66a0c216b33d1
Autor:
María, Rodríguez-Sanz, Marta, Pineda-Moncusí, Sonia, Servitja, Natalia, Garcia-Giralt, Tamara, Martos, Ignasi, Tusquets, Maria, Martínez-García, Jaime, Rodriguez-Morera, Adolfo, Diez-Perez, Joan, Albanell, Xavier, Nogués
Publikováno v:
In Bone November 2016 92:1-8
Autor:
Miguel López-Botet, Joan Albanell, Ana Lluch, Carlos Vilches, Ana Rovira, Pilar Eroles, Sara Santana-Hernández, Laura Comerma, Laura Soria, María Martínez-García, Andrea Vera, Gemma Heredia, María Teresa Martínez, Ignasi Tusquets, Laia Serrano, Manuela Moraru, Oriol Arpí, Marcel Costa-García, Federico Rojo, Sandra Pérez-Buira, Begoña Bermejo, Mariona Cabo, Sònia Servitja, Aura Muntasell
Natural killer (NK) cells can orchestrate effective antitumor immunity. The presence of tumor-infiltrating NK cells in diagnostic biopsies predicts pathologic complete response (pCR) to HER2-specific therapeutic antibodies in patients with primary br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5efee955b03a6fc572b6e8fe6efaed
https://doi.org/10.1158/2326-6066.c.6550095.v1
https://doi.org/10.1158/2326-6066.c.6550095.v1
Autor:
Miguel López-Botet, Joan Albanell, Ana Lluch, Carlos Vilches, Ana Rovira, Pilar Eroles, Sara Santana-Hernández, Laura Comerma, Laura Soria, María Martínez-García, Andrea Vera, Gemma Heredia, María Teresa Martínez, Ignasi Tusquets, Laia Serrano, Manuela Moraru, Oriol Arpí, Marcel Costa-García, Federico Rojo, Sandra Pérez-Buira, Begoña Bermejo, Mariona Cabo, Sònia Servitja, Aura Muntasell
Supplementary Figures 1-6 and Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7644965ef2ac1be46eb1c0ef4931129d
https://doi.org/10.1158/2326-6066.22542945.v1
https://doi.org/10.1158/2326-6066.22542945.v1
Autor:
Joan Albanell, Ana Rovira, Federico Rojo, Atanasio Pandiella, Ana Lluch, Ignasi Tusquets, Joaquin Arribas, Pilar Eroles, Juan Madoz-Gúrpide, Paula González-Alonso, Cristina Chamizo, Sandra Zazo, Maria Martínez-García, Aura Muntasell, Marta Salido, Laia Serrano, Montserrat Arumi-Uria, Silvia Menendez, Sara García-Alonso, Oriol Arpí, Sonia Servitja, Cristina Guardia, Gabriel Gil-Gómez, MohammadA Sabbaghi
Effects of T-DM1 on 750 cyclin B1 (CCNB1) mRNA expression in T751 DM1 sensitive and resistant breast cancer cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507875c041da47b06c113042ab33150a
https://doi.org/10.1158/1078-0432.22463774.v1
https://doi.org/10.1158/1078-0432.22463774.v1